MHC class I and II expression in juvenile dermatomyositis skeletal muscle

Clinical and Experimental Rheumatology

Volumn 27, Issue 3, 2009, Pages 519-526

  Sallum, Adriana M E ^a   Kiss, Maria H B ^a   Silva, Clovis A A ^a   Wakamatsu, Aida ^a   Sachetti, Silvana ^a   Lotufo, Simone ^a   Matsumura, Norio ^a   Marie, Suely K N ^a  

^a NONE

Author keywords

Idiopathic inflammatory myopathies; Juvenile dermatomyositis; MHC class I; MHC class II; Muscle biopsy

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE DURATION; DISEASE MARKER; FEMALE; FROZEN SECTION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; JUVENILE DERMATOMYOSITIS; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; ONSET AGE; POLYMYOSITIS; PRIORITY JOURNAL; SKELETAL MUSCLE;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENES, MHC CLASS II; HLA ANTIGENS; HUMANS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; POLYMYOSITIS;

EID: 67651163810     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. DALAKAS MC: Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37: 74-86.
2. DALAKAS MC: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991; 325: 1487-1498
3. LUNDBERG IE: The physiology of inflammatory myopathies: an overview. Acta Physiol Scand 2001; 171: 207-213
4. RIDER L: Childhood myositis: newly recognized diversity, pp 716-717 In: PLOTZ, P. moderator. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995; 122: 715-24.
5. BANKER BQ, VICTOR M: Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966; 45: 261-289
6. JERUSALEM F, RAKUSA M, ENGEL AG, MACDONALD RD: Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies. J Neurol Sci 1974; 23: 391-401.
7. CARPENTER S, KARPATI G, ROTHMAN S et al.: The childhood type of dernatomyositis. Neurology (Minneap.) 1976; 26: 952-962
8. WHITAKER JN, ENGEL WK: Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 1972; 286: 333-338
9. KISSEL JT, MENDELL JR, RAMMOHAN KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986; 314: 329-334 (Pubitemid 16166259)
10. EMSLIE-SMITH AM, ENGEL AG: Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27: 343-356
11. GONÇALVES FG, CHIMELLI L, SALLUM AM et al.: Immunohistochemical analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis. J Rheum 2002; 29: 1301-1307
12. LOZADA CJ, LEVIN RL, WHITLOW MS et al.: Immune complex vasculitis revisited: C1q receptors promote expression of adhesive molecules on endothelial cells. Arthritis Rheum 1994; 37: S426.
13. CID MC, GRAU JM, CASADEMONT J et al.: Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (II). Clin Exp Immunol 1996; 104: 467-473
14. SHREENIWAS R, KOGA S, KARAKURUM M et al.: Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992; 90: 2333-2339
15. SALLUM AME, VIANNA MAAG, WAKAMATSU A et al.: Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis. J Rheumatol 2004; 31: 801-807
16. LI CK, VARSANI H, HOLTON JL et al.: Juvenile dermatomyositis research group. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 2004; 31: 605-609
17. BOHAN A, PETER JB: Polymyositis and dermatomyositis. N Engl J Med 1975; 13: 344-347
18. SALLUM AME, KISS MHB, SACHETTI S et al.: Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr 2002; 60: 889-899
19. nd ed. In: SAUNDERS Histological and Histochemical Stains and Reactions, 1985. Section 1, p. 19-40.
20. KALOVIDOURUS AE: The role of cell mediated immunity in polymyositis. Curr Opin Rheumatol 1991; 3: 911-918
21. KARPATI G, POULIOT Y, CARPENTER S: Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23: 64-72.
22. MCDOUALL RM, DUNN MJ, DUBOWITZ V: Expression of Class I and Class II antigens in neuromuscular diseases. J Neurol Sci 1989; 89: 213-226 (Pubitemid 19052952)
23. EMSLIE-SMITH AM, ARAHATA K, ENGEL AG: Major histocompatibility complex class 1 antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in miopathies. Hum Pathol 1989; 20: 224-231 (Pubitemid 19081957)
24. ISENBERG DA, ROWE D, SHEARER M et al.: Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 1986; 63: 450-458
25. ROWE D, ISENBERG DA, BEVERLEY PCL: Monoclonal antibosies to immune leukocyte antigens in polymyositis and muscular dystrophy. Clin Exp Immunol 1983; 54: 327-36.
26. ENGLUND P, LINDROOS E, NENNESMO I et al.: Skeletal muscle fibres express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 2001; 159: 1263-1273
27. BARTOCCIONI E, GALLUCCI S, SCUDERI F et al.: MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994; 95: 166-172
28. FLADBY T, KAMPMAN MT, LOSETH S et al.: Human leukocyte antigen class I in polymyositis: leukocyte infiltrates, regeneration and impulse block. Muscle Nerve 1997; 20: 1534-1540
29. LINDBERG C, OLDFORS A, TARKOWSKI A: Local T-cell proliferation and differentiation in inflammatory myopathies. Scand J Immunol 1995; 41: 421-426
30. APPLEYARD ST, DUBOWITZ V, DUNN MJ et al.: Increased expression of HLA ABC Class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1985; 16: 361-363
31. NYBERG P, WIKMAN AL, NENNESMO I et al.: Increased expression of interleukin 1μ and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000; 27: 940-948
32. TOPALOGLU H, MUNTONI F, DUBOWITZ V et al.: Expression of HLA class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis. J Child Neurol 1997; 12: 60-63
33. MCCANN LJ, LI CKC, VARSANI H et al.: Failure to over express MHC-CLASS-1 on muscle biopsy in a case of amyopathic juvenile dermatomyositis. Clin Exp Rheumatol 2007; 25: 96-98
34. VAN DER PAS J, HENGSTMAN GJD, TER LAAK HJ et al.: Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004; 75: 136-139
35. OLSSON T, HENRIKSSON KG, KLARESKOG L et al.: HLA-DR expression, T lymphocyte phenotypes, OKM1 and OKT9 reactive cells in inflammatory myopathy. Muscle Nerve 1985; 8: 419-425
36. AKIRA I, SATOSI K, YIDENG L et al.: Expression of HLA-DR and its enhancing molecules in muscle fibres in polymyositis. Muscle Nerve 2000; 23: 385-392
37. ZUK JA, FLETCHER A: Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate. J Clin Pathol 1988; 41: 410-414
38. KUMAMONO T, ABE T, UEYAMA H et al.: Elevated soluble intercellular adhesion molecules-1 in inflammatory myopathy. Acta Neurol Scand 1997; 95: 34-37
39. NAGARAJU K, RABEN N, LOEFFER L: Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis specific autoantibodies. Proc Natl Acad Sci USA 2000; 97: 9209-9214